Colgate-Palmolive (NYSE:CL) Shares Bought by Eagle Ridge Investment Management

Eagle Ridge Investment Management raised its position in Colgate-Palmolive (NYSE:CL) by 10.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 18,357 shares of the company’s stock after acquiring an additional 1,800 shares during the quarter. Eagle Ridge Investment Management’s holdings in Colgate-Palmolive were worth $1,463,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC lifted its stake in Colgate-Palmolive by 12.2% in the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 3,034 shares of the company’s stock worth $216,000 after purchasing an additional 329 shares in the last quarter. Harbor Capital Advisors Inc. lifted its stake in Colgate-Palmolive by 2.3% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 15,278 shares of the company’s stock worth $1,086,000 after purchasing an additional 342 shares in the last quarter. Toews Corp ADV purchased a new position in Colgate-Palmolive in the 3rd quarter worth approximately $782,000. Kingswood Wealth Advisors LLC purchased a new position in Colgate-Palmolive in the 3rd quarter worth approximately $880,000. Finally, Robeco Institutional Asset Management B.V. lifted its stake in Colgate-Palmolive by 2.6% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,468,376 shares of the company’s stock worth $104,416,000 after purchasing an additional 37,074 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the completion of the sale, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The disclosure for this sale can be found here. Over the last quarter, insiders sold 232,371 shares of company stock worth $19,505,099. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Stock Down 1.0 %

Shares of NYSE:CL traded down $0.88 during trading on Monday, hitting $90.13. The company’s stock had a trading volume of 2,385,562 shares, compared to its average volume of 4,581,458. The business has a 50 day moving average price of $87.66 and a two-hundred day moving average price of $81.63. The company has a market capitalization of $74.09 billion, a PE ratio of 28.55, a P/E/G ratio of 3.42 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.28 and a current ratio of 0.42. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $92.25.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.73 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is presently 63.29%.

Analysts Set New Price Targets

CL has been the topic of a number of research reports. Evercore ISI raised their target price on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Morgan Stanley lifted their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. The Goldman Sachs Group started coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 price target on the stock. Finally, UBS Group lifted their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $91.38.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.